Verzenio 100 MG tablet UU 14S
Ended Awarded Last action
- Contract number
- SPE2DR26F47CU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,089
Award facts
- Contract value 100% obligated
- $19,088.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,088.60 to AmerisourceBergen Drug Corp for the supply of Verzenio 100 mg tablets (14-tablet units) on January 8, 2026, with completion expected by January 9, 2026. This is a firm fixed-price contract with no set-aside designation, indicating competitive award through open competition. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's parent organization, Cencora, Inc. (doing business as AmerisourceBergen), which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031. This master contract serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen is a major pharmaceutical distributor that supplies critical medications across multiple therapeutic domains to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Verzenio (abemaciclib) is a specialized oncology medication used in breast cancer treatment, reflecting the company's role in providing specialty pharmaceuticals to military and veteran healthcare networks. As a primary vendor through its expansive IDC with DLA, AmerisourceBergen demonstrates consistent capability to fulfill federal medical procurement requirements efficiently and competitively, supporting essential pharmaceutical needs across the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26F47CU?
SPE2DR26F47CU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F47CU worth?
The government has obligated $19,089 on SPE2DR26F47CU.
Is contract SPE2DR26F47CU an order under another contract?
Yes. SPE2DR26F47CU is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47CU competed?
The extent of competition for SPE2DR26F47CU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award